The publisher would like to draw the reader’s attention to thefollowing errors. Ethics approval and consent to participate statementswere not included in the published version of the following articles thatappeared i...The publisher would like to draw the reader’s attention to thefollowing errors. Ethics approval and consent to participate statementswere not included in the published version of the following articles thatappeared in previous issues of Bioactive Materials. The authors werecontacted after publication to request ethics approval and consent toparticipate statements for the following articles. The appropriate ethicsapproval and consent to participate statements, provided by the authors,are included below.展开更多
The publisher would like to draw the reader's attention to the following errors.Ethics approval statements were not included in the published version of the following articles that appeared in previous issues of G...The publisher would like to draw the reader's attention to the following errors.Ethics approval statements were not included in the published version of the following articles that appeared in previous issues of Grain&Oil Science and Technology.The authors were contacted after publication to request ethical approval statements for the following articles.展开更多
In order to reduce the risk of non-performing loans, losses, and improve the loan approval efficiency, it is necessary to establish an intelligent loan risk and approval prediction system. A hybrid deep learning model...In order to reduce the risk of non-performing loans, losses, and improve the loan approval efficiency, it is necessary to establish an intelligent loan risk and approval prediction system. A hybrid deep learning model with 1DCNN-attention network and the enhanced preprocessing techniques is proposed for loan approval prediction. Our proposed model consists of the enhanced data preprocessing and stacking of multiple hybrid modules. Initially, the enhanced data preprocessing techniques using a combination of methods such as standardization, SMOTE oversampling, feature construction, recursive feature elimination (RFE), information value (IV) and principal component analysis (PCA), which not only eliminates the effects of data jitter and non-equilibrium, but also removes redundant features while improving the representation of features. Subsequently, a hybrid module that combines a 1DCNN with an attention mechanism is proposed to extract local and global spatio-temporal features. Finally, the comprehensive experiments conducted validate that the proposed model surpasses state-of-the-art baseline models across various performance metrics, including accuracy, precision, recall, F1 score, and AUC. Our proposed model helps to automate the loan approval process and provides scientific guidance to financial institutions for loan risk control.展开更多
The urgent need for effective cancer treatments,particularly for advanced and relapsed cases in which standard therapies are inadequate,has spurred the development of innovative therapeutic drugs1,2.Among the strategi...The urgent need for effective cancer treatments,particularly for advanced and relapsed cases in which standard therapies are inadequate,has spurred the development of innovative therapeutic drugs1,2.Among the strategies to expedite drug development,the use of single-arm trials(SATs)is emerging as a promising avenue with substantial potential to shorten drug approval timelines and accelerate market entry.展开更多
Objective To provide suggestions to improve the system of accelerated review and approval in China and to speed up the development and marketing of innovative drugs.Methods A comparative analysis was made to study the...Objective To provide suggestions to improve the system of accelerated review and approval in China and to speed up the development and marketing of innovative drugs.Methods A comparative analysis was made to study the accelerated review,conditional approval and breakthrough therapy between China and the United States.Combined with the implementation of accelerated pathway in China,some suggestions were put forward.Results and Conclusion The implementation of accelerated drug review and approval system can significantly speed up the process of new drug development,which will improve the accessibility of innovative drugs.However,there are some problems in the review procedures and the implementation of supportive documents in China.In view of the above problems and combined with the experiences of US FDA,we should strengthen the construction of institutional system and reviewer team,and improve the efficiency of drug research and development.展开更多
State Administration for Market Regulation and National Standardization Administration of China have approved the following 328 national standards and 3 national standards with amendment.
State Administration for Market Regulation and National Standardization Administration of China have approved the following 258 national standards in foreign language version.
State Administration for Market Regulation and National Standardization Administration of China have approved the following 24 mandatory national standards and 2 mandatory national standards with amendment.
State Administration for Market Regulation and National Standardization Administration of China have approved the following 20 national standards and 1 national standard with amendment.
State Administration for Market Regulation and National Standardization Administration of China have approved the following 218 national standards and 1 national standard with amendment.
State Administration for Market Regulation and Standardization Administration of China have approved the following 6 mandatory national standards and 3 mandatory national standards with amendment.
State Administration for Market Regulation and Standardization Administration of China have approved the following 34 mandatory national standards and 1 mandatory national standard with amendment.
State Administration for Market Regulation and Standardization Administration of China have approved the following 353 national standards and 4 national standards with amendment.
State Administration for Market Regulation and Standardization Administration of China have approved the following 109 national standards and 4 national standards with amendment.
State Administration for Market Regulation and Standardization Administration of China have approved the following 195 national standards and 1 national standard with amendment.
The technical problems and approval standards for the regional test of soybean varieties in Liaoning Province were discussed. The technical key points for the soybean regional trials were the selection of trial fields...The technical problems and approval standards for the regional test of soybean varieties in Liaoning Province were discussed. The technical key points for the soybean regional trials were the selection of trial fields, preparations in lab be-fore sowing, preparations in regional trial field before sowing, sowing in suitable time and strict with sowing process, field management and survey record, harvest and sampling as wel as lab test and summary. In addition, the approval standards for common varieties and quality varieties for the soybean regional trials in Liaoning were introduced, with the aim to provide accurate and scientific theoretical basis for the approval of soybean varieties.展开更多
China＇s economic growth miracle despite complicated administrative approval formalities prompted us to raise the following question： ls it true that reforming administrative approval will promote economic growth？ B...China＇s economic growth miracle despite complicated administrative approval formalities prompted us to raise the following question： ls it true that reforming administrative approval will promote economic growth？ Based on our analysis on market entry, we discovered that reforming administrative approval will spur economic growth by reducing transaction cost for firms. Administrative approval may suppress social cost and propel China＇s economic growth; China＇s gradualist approval reforms may indeed propel economic growth by reducing transaction cost for firms. With the data of prefecture-level cities during 2000-2013 and data of companies listed on the SME board during 2010-2014, we tested the effects of approval reforms on economic growth and on transaction cost, and employed instrumental variable and PSM for the treatment of the endogeneity problem - all these tests led to robust and consistent results. Moreover, we discovered that difference in government policy implementation in the approval process is the root cause of corruption and rent seeking.展开更多
文摘The publisher would like to draw the reader’s attention to thefollowing errors. Ethics approval and consent to participate statementswere not included in the published version of the following articles thatappeared in previous issues of Bioactive Materials. The authors werecontacted after publication to request ethics approval and consent toparticipate statements for the following articles. The appropriate ethicsapproval and consent to participate statements, provided by the authors,are included below.
文摘The publisher would like to draw the reader's attention to the following errors.Ethics approval statements were not included in the published version of the following articles that appeared in previous issues of Grain&Oil Science and Technology.The authors were contacted after publication to request ethical approval statements for the following articles.
文摘In order to reduce the risk of non-performing loans, losses, and improve the loan approval efficiency, it is necessary to establish an intelligent loan risk and approval prediction system. A hybrid deep learning model with 1DCNN-attention network and the enhanced preprocessing techniques is proposed for loan approval prediction. Our proposed model consists of the enhanced data preprocessing and stacking of multiple hybrid modules. Initially, the enhanced data preprocessing techniques using a combination of methods such as standardization, SMOTE oversampling, feature construction, recursive feature elimination (RFE), information value (IV) and principal component analysis (PCA), which not only eliminates the effects of data jitter and non-equilibrium, but also removes redundant features while improving the representation of features. Subsequently, a hybrid module that combines a 1DCNN with an attention mechanism is proposed to extract local and global spatio-temporal features. Finally, the comprehensive experiments conducted validate that the proposed model surpasses state-of-the-art baseline models across various performance metrics, including accuracy, precision, recall, F1 score, and AUC. Our proposed model helps to automate the loan approval process and provides scientific guidance to financial institutions for loan risk control.
基金supported by grants from the China Society for Drug Regulation(Grant No.2023-Y-Y-002)。
文摘The urgent need for effective cancer treatments,particularly for advanced and relapsed cases in which standard therapies are inadequate,has spurred the development of innovative therapeutic drugs1,2.Among the strategies to expedite drug development,the use of single-arm trials(SATs)is emerging as a promising avenue with substantial potential to shorten drug approval timelines and accelerate market entry.
文摘Objective To provide suggestions to improve the system of accelerated review and approval in China and to speed up the development and marketing of innovative drugs.Methods A comparative analysis was made to study the accelerated review,conditional approval and breakthrough therapy between China and the United States.Combined with the implementation of accelerated pathway in China,some suggestions were put forward.Results and Conclusion The implementation of accelerated drug review and approval system can significantly speed up the process of new drug development,which will improve the accessibility of innovative drugs.However,there are some problems in the review procedures and the implementation of supportive documents in China.In view of the above problems and combined with the experiences of US FDA,we should strengthen the construction of institutional system and reviewer team,and improve the efficiency of drug research and development.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 328 national standards and 3 national standards with amendment.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 258 national standards in foreign language version.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 24 mandatory national standards and 2 mandatory national standards with amendment.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 20 national standards and 1 national standard with amendment.
文摘State Administration for Market Regulation and National Standardization Administration of China have approved the following 218 national standards and 1 national standard with amendment.
文摘State Administration for Market Regulation and Standardization Administration of China have approved the following 6 mandatory national standards and 3 mandatory national standards with amendment.
文摘State Administration for Market Regulation and Standardization Administration of China have approved the following 34 mandatory national standards and 1 mandatory national standard with amendment.
文摘State Administration for Market Regulation and Standardization Administration of China have approved the following 353 national standards and 4 national standards with amendment.
文摘State Administration for Market Regulation and Standardization Administration of China have approved the following 109 national standards and 4 national standards with amendment.
文摘State Administration for Market Regulation and Standardization Administration of China have approved the following 195 national standards and 1 national standard with amendment.
基金Supported by the Research Station Program of the National Soybean Industrial Technology R&D System of China(CARS-04)~~
文摘The technical problems and approval standards for the regional test of soybean varieties in Liaoning Province were discussed. The technical key points for the soybean regional trials were the selection of trial fields, preparations in lab be-fore sowing, preparations in regional trial field before sowing, sowing in suitable time and strict with sowing process, field management and survey record, harvest and sampling as wel as lab test and summary. In addition, the approval standards for common varieties and quality varieties for the soybean regional trials in Liaoning were introduced, with the aim to provide accurate and scientific theoretical basis for the approval of soybean varieties.
文摘China＇s economic growth miracle despite complicated administrative approval formalities prompted us to raise the following question： ls it true that reforming administrative approval will promote economic growth？ Based on our analysis on market entry, we discovered that reforming administrative approval will spur economic growth by reducing transaction cost for firms. Administrative approval may suppress social cost and propel China＇s economic growth; China＇s gradualist approval reforms may indeed propel economic growth by reducing transaction cost for firms. With the data of prefecture-level cities during 2000-2013 and data of companies listed on the SME board during 2010-2014, we tested the effects of approval reforms on economic growth and on transaction cost, and employed instrumental variable and PSM for the treatment of the endogeneity problem - all these tests led to robust and consistent results. Moreover, we discovered that difference in government policy implementation in the approval process is the root cause of corruption and rent seeking.
